Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMedOpen access

Adipose tissue as a living drug: Stromal vascular fraction and adipose tissue-derived stem cells in regenerative medicine.

Choudhery MS., Niaz A., Arif T., Mahmood R.

Narrative Review on Immune Modulation, published in World J Stem Cells (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
World J Stem Cells (2025)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
41480399
PMCID
PMC12754547
DOI
10.4252/wjsc.v17.i12.114170

Abstract (original English)

Adipose tissue has emerged as a rich and clinically relevant source of regenerative cells. It offers a minimally invasive, abundant, and autologous reservoir for therapeutic applications. Among its cellular components, the stromal vascular fraction (SVF) and adipose-derived stem cells (ASCs) have gained considerable attention due to their potent regenerative and immunomodulatory capacities. SVF is a heterogeneous mixture of cells, whereas ASCs constitute a more homogeneous mesenchymal stem cell-like population obtained through in vitro expansion. Together, these cell populations (SVF and ASCs) are described as "living drugs", as they are viable and act as dynamic biological agents within the body. Unlike conventional medicines, living drugs exert therapeutic effects not only through direct differentiation but also via the secretion of bioactive molecules, including cytokines, growth factors, and extracellular vesicles. These secreted factors can modulate the surrounding microenvironment, enhance tissue repair, and regulate immune responses. Such paracrine mechanisms often play a more significant role than direct cell replacement, making living drugs versatile tools for regenerative medicine. This review provides a comprehensive overview of SVF and ASCs as living drugs. It discusses their cellular composition, mechanisms of action, methods of isolation, and the regenerative biom

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research